| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |